Vaccine co-administration in adults: An effective way to improve vaccination coverage

References

• Eurostat. Population structure and ageing. 2021 [accessed 2021 Dec 7]. https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Population_structure_and_ageing#Slightly_more_than_three_persons_of_working_age_for_every_person_aged_65_or_over.
   Google Scholar
• Harder T, Koch J, Vygen-Bonnet S, Külper-Schiek W, Pilic A, Reda S, Scholz S, Wichmann O. Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a living systematic review, 1 January to 14 May 2021. Euro Surveill. 2021;26(28):2100563. doi:10.2807/1560-7917.es.2021.26.28.2100563.
   PubMedGoogle Scholar
• Doherty TM, Connolly MP, Del Giudice G, Flamaing J, Goronzy JJ, Grubeck-Loebenstein B, Lambert PH, Maggi S, McElhaney JE, Nagai H, et al. Vaccination programs for older adults in an era of demographic change. Eur Geriatr Med. 2018;9(3):289–6. doi:10.1007/s41999-018-0040-8.
   PubMed Web of Science ®Google Scholar
• ECDC. Vaccine schedules in all countries in the EU/EEA. 2021 [accessed 2021 Dec 7]. https://vaccine-schedule.ecdc.europa.eu/.
   Google Scholar
• Bonanni P, Bonaccorsi G, Lorini C, Santomauro F, Tiscione E, Boccalini S, Bechini A. Focusing on the implementation of 21st century vaccines for adults. Vaccine. 2018;36(36):5358–65. doi:10.1016/j.vaccine.2017.07.100.
   PubMed Web of Science ®Google Scholar
• Privor-Dumm LA, Poland GA, Barratt J, Durrheim DN, Deloria Knoll M, Vasudevan P, Jit M, Bonvehí PE, Bonanni P. A global agenda for older adult immunization in the COVID-19 era: a roadmap for action. Vaccine. 2021;39(37):5240–50. doi:10.1016/j.vaccine.2020.06.082.
   PubMed Web of Science ®Google Scholar
• ECDC. COVID-19 vaccine tracker. 2021 [accessed 2021 Dec 7]. https://qap.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab.
   Google Scholar
• Rizzo C, Rezza G, Ricciardi W. Strategies in recommending influenza vaccination in Europe and US. Hum Vaccin Immunother. 2018;14(3):693–8. doi:10.1080/21645515.2017.1367463.
   PubMed Web of Science ®Google Scholar
• Lin CJ, Nowalk MP, Pavlik VN, Brown AE, Zhang S, Raviotta JM, Moehling KK, Hawk M, Ricci EM, Middleton DB, et al. Using the 4 pillars™ practice transformation program to increase adult influenza vaccination and reduce missed opportunities in a randomized cluster trial. BMC Infect Dis. 2016;16(1):623. doi:10.1186/s12879-016-1940-1.
   PubMedGoogle Scholar
• WHO. Increasing RI coverage by reducing missed opportunities for vaccination. [accessed 2022 Aug 23]. https://cdn.who.int/media/docs/default-source/immunization/mov/who-mov-materials-2pager-l3.pdf?sfvrsn=dfdbba0_6.
   Google Scholar
• CDC. Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States. Coadministration of COVID-19 vaccines with other vaccines. 2021 [accessed 2021 Dec 7]. https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html#Coadministration.
   Google Scholar
• WHO. Coadministration of seasonal inactivated influenza and COVID-19 vaccines: interim guidance. 2021 [accessed 2021 Dec 7]. https://apps.who.int/iris/rest/bitstreams/1382850/retrieve.
   Google Scholar
• Koch J, Wichmann O, Mertens T. STIKO-Empfehlung zur Koadministration von COVID-19-Impfstoffen und anderen Totimpfstoffen und die dazugehörige wissenschaftliche Begründung. Epid Bull. 2021;39:42–5 doi:10.25646/9044.
   Google Scholar
• Hoge Gezondheidsraad . Gelijktijdige toediening van vaccins tegen COVID-19 met andere vaccins (simultane vaccinatie). [Co-administration of vaccines against COVID-19 with other vaccines (simultaneous vaccination)]. 2021 [accessed 2021 Dec 7]. https://www.health.belgium.be/sites/default/files/uploads/fields/fpshealth_theme_file/20211006_hgr-9675_simultane_vaccinatie_covid19_vweb.pdf.
   Google Scholar
• Karlsson EA, Beck MA. The burden of obesity on infectious disease. Exp Biol Med. 2010;235(12):1412–24. doi:10.1258/ebm.2010.010227.
   Web of Science ®Google Scholar
• Sappenfield E, Jamieson DJ, Kourtis AP. Pregnancy and susceptibility to infectious diseases. Infect Dis Obstet Gynecol. 2013;2013:752852. doi:10.1155/2013/752852.
   PubMedGoogle Scholar
• McGrath B, Broadhurst M, Roman C. Infectious disease considerations in immunocompromised patients. JAAPA. 2020;33(9):16–25. doi:10.1097/01.JAA.0000694948.01963.f4.
   PubMedGoogle Scholar
• Lange P. Chronic obstructive pulmonary disease and risk of infection. Pneumonol Alergol Pol. 2009;77(3):284–8. doi:10.5603/ARM.27817.
   PubMedGoogle Scholar
• Bender BS. Infectious disease risk in the elderly. Immunol Allergy Clin North Am. 2003;23(1):57–64, vi. doi:10.1016/s0889-8561(02)00078-4.
   PubMed Web of Science ®Google Scholar
• Vento S, Cainelli F. Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment. Lancet Oncol. 2003;4(10):595–604. doi:10.1016/s1470-2045(03)01218-x.
   PubMed Web of Science ®Google Scholar
• Chen LH, Blair BM. Infectious risks of traveling abroad. Microbiol Spectr. 2015;3(4). doi:10.1128/microbiolspec.IOL5-0005-2015.
   PubMedGoogle Scholar
• Levitt A, Mermin J, Jones CM, See I, Butler JC. Infectious diseases and injection drug use: public health burden and response. J Infect Dis. 2020;222(Supplement_5):S213–7. doi:10.1093/infdis/jiaa432.
   PubMedGoogle Scholar
• Vaisrub S. Homosexuality—a risk factor in infectious disease. JAMA. 1977;238(13):1402. doi:10.1001/jama.1977.03280140080031.
   PubMed Web of Science ®Google Scholar
• Jiang C, Chen Q, Xie M. Smoking increases the risk of infectious diseases: a narrative review. Tob Induc Dis. 2020;18:60. doi:10.18332/tid/123845.
   PubMed Web of Science ®Google Scholar
• Morojele NK, Shenoi SV, Shuper PA, Braithwaite RS, Rehm J. Alcohol use and the risk of communicable diseases. Nutrients. 2021;13(10):3317. doi:10.3390/nu13103317.
   PubMed Web of Science ®Google Scholar
• Vousden N, Bunch K, Knight M, UKOSS Influenza Co-Investigators Group. Incidence, risk factors and impact of seasonal influenza in pregnancy: a national cohort study. PLoS One. 2021;16(1):e0244986. doi:10.1371/journal.pone.0244986.
   PubMed Web of Science ®Google Scholar
• Torres A, Blasi F, Dartois N, Akova M. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease. Thorax. 2015;70(10):984–9. doi:10.1136/thoraxjnl-2015-206780.
   PubMed Web of Science ®Google Scholar
• Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6):e004833. doi:10.1136/bmjopen-2014-004833.
   PubMed Web of Science ®Google Scholar
• Cromer D, van Hoek AJ, Jit M, Edmunds WJ, Fleming D, Miller E. The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. J Infect. 2014;68(4):363–71. doi:10.1016/j.jinf.2013.11.013.
   PubMed Web of Science ®Google Scholar
• Nasreen S, Wang J, Kwong JC, Crowcroft NS, Sadarangani M, Wilson SE, McGeer A, Kellner JD, Quach C, Morris SK, et al. Population-based incidence of invasive pneumococcal disease in children and adults in Ontario and British Columbia, 2002–2018: a Canadian Immunization Research Network (CIRN) study. Vaccine. 2021;39(52):7545–53. doi:10.1016/j.vaccine.2021.11.032.
   PubMed Web of Science ®Google Scholar
• Jenkins VA, Savic M, Kandeil W. Pertussis in high-risk groups: an overview of the past quarter-century. Hum Vaccin Immunother. 2020;16(11):2609–17. doi:10.1080/21645515.2020.1738168.
   PubMed Web of Science ®Google Scholar
• Kandeil W, Atanasov P, Avramioti D, Fu J, Demarteau N, Li X. The burden of pertussis in older adults: what is the role of vaccination? A systematic literature review. Expert Rev Vaccines. 2019;18(5):439–55. doi:10.1080/14760584.2019.1588727.
   PubMed Web of Science ®Google Scholar
• Aris E, Harrington L, Bhavsar A, Simeone JC, Ramond A, Papi A, Vogelmeier CF, Meszaros K, Lambrelli D, Mukherjee P. Burden of pertussis in COPD: a retrospective database study in England. COPD. 2021;18(2):157–69. doi:10.1080/15412555.2021.1899155.
   PubMedGoogle Scholar
• CDC. Adult immunization schedule: recommendations for ages 19 years or older, United States. 2022 [accessed 2022 Aug 23]. https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html.
   Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis and management of chronic obstructive lung disease: 2022 report. 2021 [accessed 2021 Dec 7]. https://goldcopd.org/wp-content/uploads/2021/12/GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf.
   Google Scholar
• CDC. Lung disease including asthma and adult vaccination. [accessed 2021 Dec 7]. https://www.cdc.gov/vaccines/adults/rec-vac/health-conditions/lung-disease.html.
   Google Scholar
• Philip RK, Attwell K, Breuer T, Di Pasquale A, Lopalco PL. Life-course immunization as a gateway to health. Expert Rev Vaccines. 2018;17(10):851–64. doi:10.1080/14760584.2018.1527690.
   PubMed Web of Science ®Google Scholar
• Hua L, Hongtao H, Shunqin W, Jinping G, Jiandong C, Zhaoliang L, Xinwen F. Simultaneous vaccination of Chinese applicants for a United States immigrant visa. Travel Med Infect Dis. 2008;6(3):130–6. doi:10.1016/j.tmaid.2008.03.004.
   PubMedGoogle Scholar
• Mizuno Y, Kano S, Urashima M, Genka I, Kanagawa S, Kudo K. Simultaneous vaccination in Japanese travelers. Travel Med Infect Dis. 2007;5(2):85–9. doi:10.1016/j.tmaid.2006.09.001.
   PubMedGoogle Scholar
• Lu PJ, Hung MC, Srivastav A, Grohskopf LA, Kobayashi M, Harris AM, Dooling KL, Markowitz LE, Rodriguez-Lainz A, Williams WW. Surveillance of vaccination coverage among adult populations-United States, 2018. MMWR Surveill Summ. 2021;70(3):1–26. doi:10.15585/mmwr.ss7003a1.
   PubMed Web of Science ®Google Scholar
• Garbinsky D, Hunter S, La EM, Poston S, Hogea C. State-level variations and factors associated with adult vaccination coverage: a multilevel modeling approach. Pharmacoecon Open. 2021;5(3):411–23. doi:10.1007/s41669-021-00262-x.
   PubMed Web of Science ®Google Scholar
• de Gomensoro E, Del Giudice G, Doherty TM. Challenges in adult vaccination. Ann Med. 2018;50(3):181–92. doi:10.1080/07853890.2017.1417632.
   PubMed Web of Science ®Google Scholar
• Bonanni P, Boccalini S, Bechini A, Varone O, Matteo G, Sandri F, Gabutti G. Co-administration of vaccines: a focus on tetravalent Measles-Mumps-Rubella-Varicella (MMRV) and meningococcal C conjugate vaccines. Hum Vaccin Immunother. 2020;16(6):1313–21. doi:10.1080/21645515.2019.1688032.
   PubMed Web of Science ®Google Scholar
• Turner N, Grant C, Goodyear-Smith F, Petousis-Harris H. Seize the moments: missed opportunities to immunize at the family practice level. Fam Pract. 2009;26(4):275–8. doi:10.1093/fampra/cmp028.
   PubMed Web of Science ®Google Scholar
• CDC. Timing and spacing of immunobiologics. General best practice guidelines for immunization: best practices guidance of the Advisory Committee on Immunization Practices (ACIP). 2021 [accessed 2021 Dec 7]. https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html.
   Google Scholar
• Frenck RW Jr., Gurtman A, Rubino J, Smith W, van Cleeff M, Jayawardene D, Giardina PC, Emini EA, Gruber WC, Scott DA, et al. Randomized, controlled trial of a 13-valent pneumococcal conjugate vaccine administered concomitantly with an influenza vaccine in healthy adults. Clin Vaccine Immunol. 2012;19(8):1296–303. doi:10.1128/cvi.00176-12.
   PubMed Web of Science ®Google Scholar
• Song JY, Cheong HJ, Tsai TF, Chang HA, Choi MJ, Jeon JH, Kang SH, Jeong EJ, Noh JY, Kim WJ. Immunogenicity and safety of concomitant MF59-adjuvanted influenza vaccine and 23-valent pneumococcal polysaccharide vaccine administration in older adults. Vaccine. 2015;33(36):4647–52. doi:10.1016/j.vaccine.2015.05.003.
   PubMed Web of Science ®Google Scholar
• Domnich A, Grassi R, Fallani E, Ciccone R, Bruzzone B, Panatto D, Ferrari A, Salvatore M, Cambiaggi M, Vasco A, et al. Acceptance of COVID-19 and influenza vaccine co-administration: insights from a representative Italian survey. J Pers Med. 2022;12(2):139. doi:10.3390/jpm12020139.
   PubMed Web of Science ®Google Scholar
• CDC. Administering shingrix. [accessed 2021 Dec 7]. https://www.cdc.gov/vaccines/vpd/shingles/hcp/shingrix/administering-vaccine.html.
   Google Scholar
• CDC. Contraindications and precautions. General best practice guidelines for immunization: best practices guidance of the Advisory Committee on Immunization Practices (ACIP). 2021 [accessed 2021 Dec 7]. https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/contraindications.html.
   Google Scholar
• Bauwens J, Saenz LH, Reusser A, Künzli N, Bonhoeffer J. Safety of co-administration versus separate administration of the same vaccines in children: a systematic literature review. Vaccines. 2019;8(1):12. doi:10.3390/vaccines8010012.
   Web of Science ®Google Scholar
• CDC. Multiple vaccinations at once. 2021 [accessed 2021 Dec 7]. https://www.cdc.gov/vaccinesafety/concerns/multiple-vaccines-immunity.html.
   Google Scholar
• Hill HA, Yankey D, Elam-Evans LD, Singleton JA, Pingali SC, Santibanez TA. Vaccination coverage by age 24 months among children born in 2016 and 2017 - national immunization survey-child, United States, 2017–2019. MMWR Morb Mortal Wkly Rep. 2020;69(42):1505–11. doi:10.15585/mmwr.mm6942a1.
   PubMed Web of Science ®Google Scholar
• Bechini A, Boccalini S, Ninci A, Zanobini P, Sartor G, Bonaccorsi G, Grazzini M, Bonanni P. Childhood vaccination coverage in Europe: impact of different public health policies. Expert Rev Vaccines. 2019;18(7):693–701. doi:10.1080/14760584.2019.1639502.
   PubMed Web of Science ®Google Scholar
• Börner N, Mühlberger N, Jelinek T. Tolerability of multiple vaccinations in travel medicine. J Travel Med. 2003;10(2):112–16. doi:10.2310/7060.2003.31690.
   PubMed Web of Science ®Google Scholar